Ann M. Leen's Net Worth
$94.2 Thousand
Who is Ann M. Leen?
Ann M. Leen does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Allovir, Inc., and Marker Therapeutics, Inc..
SEC CIK
Ann M. Leen's CIK is 0001763026
Past Insider Trading and Trends
2022 was Ann M. Leen's most active year for acquiring shares with 5 total transactions. Ann M. Leen's most active month to acquire stocks was the month of December. 2020 was Ann M. Leen's most active year for disposing of shares, totalling 1 transactions. Ann M. Leen's most active month to dispose stocks was the month of October. 2020 saw Ann M. Leen paying a total of $0.00 for 257,600 shares, this is the most they've acquired in one year. In 2020 Ann M. Leen cashed out on 60,394 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Allovir, Inc. (ALVR) Snapshot price: $0.76
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +74.83% | 81.01K |
—
|
—
| 189.26K |
Jan 18 - Feb 2
| |||
Form 4
| +53.57% | 15K |
—
|
—
| 43K |
Aug 16
| |||
Form 4
| -0.91% | -20.99K |
$22.18 | -$465,559.20 | 2.29M |
Scheduled
|
Nov 12 - Nov 16
| ||
Form 4
| -6.10% | -150.00K |
$22.75 | -$3,412,500.00 | 2.31M |
May 10
| |||
Form 4
| -0.12% | -3.02K |
$30.00 | -$90,750.91 | 2.46M |
Scheduled
|
Mar 16
| ||
Form 4
| -0.39% | -9.52K |
$38.70 | -$368,329.21 | 2.46M |
Scheduled
|
Mar 1
| ||
Form 4
| -0.70% | -17.45K |
$41.48 | -$723,624.58 | 2.47M |
Scheduled
|
Feb 19 - Feb 23
| ||
Form 4
| -0.11% | -2.70K |
$40.81 | -$110,194.24 | 2.49M |
Scheduled
|
Feb 18
| ||
Form 4
| -0.21% | -5.34K |
$41.27 | -$220,200.62 | 2.49M |
Scheduled
|
Feb 16 - Feb 17
| ||
Form 4
| +46.36% | 28K |
—
|
—
| 88.39K |
Nov 30 - Jan 19
| |||
Form 4
|
∞
| 2.44M |
—
|
—
| 2.44M |
Aug 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Marker Therapeutics, Inc. (MRKR) Snapshot price: $3.17
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |